首页> 美国卫生研究院文献>Infection and Immunity >Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.
【2h】

Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.

机译:通过脂多糖-脂质A相关蛋白复合物免疫,保护C3H / HeJ小鼠免受鼠伤寒鼠伤寒沙门氏菌LT2感染。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

C3H/HeJ mice were immunized intraperitoneally (i.p.) with lipopolysaccharide (LPS)-lipid A-associated protein (LAP) complexes or with purified protein-free LPS prior to lethal i.p. or intravenous Salmonella typhimurium LT2 challenge. Our results demonstrated that these Salmonella-hypersusceptible mice can be effectively protected against 1,000 100% lethal doses of S. typhimurium LT2 (i.e., 1,000 viable bacteria) administered by intravenous challenge when previously immunized with LAP-LPS complexes. In contrast to these results, immunization with LPS afforded markedly less protection regardless of the route of challenge, thus suggesting that the LAP portion of LAP-LPS complexes may be necessary for inducing protection against Salmonella infections. For most experiments, antigens were emulsified in complete Freund adjuvant (CFA); however, the CFA portion of the vaccine was suggested not to be an essential component for the induction of immunity to Salmonella infections, since equivalent levels of protection were obtained when it was omitted from the vaccine. The induction of immunity to murine salmonellosis by prior immunization with CFA-LAP-LPS was demonstrated not to be a transient phenomenon, since C3H/HeJ mice were still protected against lethal S. typhimurium LT2 challenge as late as 225 days postimmunization.
机译:C3H / HeJ小鼠在致死性腹膜内免疫之前,先用脂多糖(LPS)-脂质A相关蛋白(LAP)复合物或纯化的无蛋白LPS腹膜内(i.p.)免疫。或静脉注射鼠伤寒沙门氏菌LT2。我们的结果表明,当先前用LAP-LPS复合物免疫后,这些沙门氏菌敏感性高的小鼠可以通过静脉内攻击有效防御1,000 100%致死剂量的鼠伤寒沙门氏菌LT2(即1,000种活菌)。与这些结果相反,无论挑战的途径如何,用LPS免疫均能提供明显较少的保护,因此表明LAP-LPS复合物的LAP部分对于诱导针对沙门氏菌感染的保护可能是必需的。对于大多数实验,抗原是在完全弗氏佐剂(CFA)中乳化的;但是,建议疫苗的CFA部分不是诱导沙门氏菌感染免疫力的必要组成部分,因为当从疫苗中省略疫苗时,可以获得同等水平的保护。事实证明,事先用CFA-LAP-LPS免疫可诱导鼠类沙门氏菌免疫,并非暂时现象,因为C3H / HeJ小鼠在免疫后225天仍能抵抗鼠伤寒沙门氏菌LT2的攻击。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号